Related Experiment Video
Updated: May 30, 2026
08:22
Orthotopic Left Lung Transplantation in Rats
Published on: July 3, 2025
Lung transplantation for end-stage silicosis
Wen-Jun Mao1, Jing-Yu Chen, Ming-Feng Zheng
1Lung Transplant Group, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China.
Journal of Occupational and Environmental Medicine
|July 26, 2011
Summary
Lung transplantation shows promising survival rates for end-stage silicosis patients. This lung surgery offers effective treatment for severe respiratory disease, improving quality of life.
Area of Science:
- Pulmonology
- Thoracic Surgery
- Transplant Medicine
Background:
- Silicosis is a progressive fibrotic lung disease caused by silica dust inhalation.
- End-stage silicosis leads to severe respiratory compromise and limited treatment options.
- Lung transplantation is a potential therapeutic option for select patients.
Observation:
- A retrospective analysis of five patients with end-stage silicosis who underwent lung transplantation.
- Four patients received single lung transplantation, and one underwent bilateral lung transplantation.
- Extracorporeal membrane oxygenation (ECMO) was required in four patients, with successful weaning in three.
Findings:
- No perioperative mortality was observed.
- One patient experienced primary graft dysfunction and died postoperatively.
- Four patients were discharged, with three surviving long-term (5, 3, and 2 years) with good quality of life and return to work.
Implications:
- Lung transplantation can be an effective therapy for end-stage silicosis.
- Successful outcomes suggest potential for improved survival and quality of life.
- Further research is warranted to optimize patient selection and management.
